Metronidazole and Secnidazole Carbamates: Synthesis, Antiprotozoal Activity, and Molecular Dynamics Studies
Genaro Rocha-Garduño,
Norma Angélica Hernández-Martínez,
Blanca Colín-Lozano,
Samuel Estrada-Soto,
Emanuel Hernández-Núñez,
Fernando Daniel Prieto-Martínez,
José L. Medina-Franco,
Juan Bautista Chale-Dzul,
Rosa Moo-Puc,
Gabriel Navarrete-Vázquez
Affiliations
Genaro Rocha-Garduño
Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos 62209, Mexico
Norma Angélica Hernández-Martínez
Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos 62209, Mexico
Blanca Colín-Lozano
Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos 62209, Mexico
Samuel Estrada-Soto
Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos 62209, Mexico
Emanuel Hernández-Núñez
Cátedra CONACyT, Departamento de Recursos del Mar, Centro de Investigación y de Estudios Avanzados del IPN, Unidad Mérida, Yucatán 97310, Mexico
Fernando Daniel Prieto-Martínez
Facultad de Química, Departamento de Farmacia, Universidad Nacional Autónoma de México, México City 04510, Mexico
José L. Medina-Franco
Facultad de Química, Departamento de Farmacia, Universidad Nacional Autónoma de México, México City 04510, Mexico
Juan Bautista Chale-Dzul
Laboratorio de Apoyo a la Vigilancia Epidemiológica, Hospital de Especialidades 1, Centro Médico Nacional Ignacio García Téllez, Instituto Mexicano del Seguro Social, Mérida 97150, Yucatán, Mexico
Rosa Moo-Puc
Unidad de Investigación Médica Yucatán, Unidad Médica de Alta Especialidad, Centro Médico Nacional Ignacio García Téllez, Instituto Mexicano del Seguro Social, Mérida 97000, Yucatán, Mexico
Gabriel Navarrete-Vázquez
Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos 62209, Mexico
We prepared a series of 10 carbamates derivatives based on two common antiprotozoal drugs: metronidazole (1−5) and secnidazole (6−10). The compounds were tested in vitro against a set of two amitochondriate protozoa: Giardia duodenalis and Trichomonas vaginalis. Compounds 1−10 showed strong antiprotozoal activities, with potency values in the low micromolar-to-nanomolar range, being more active than their parent drugs. Metronidazole carbamate (1) was the most active of the series, with nanomolar activities against G. duodenalis (IC50 = 460 nM) and T. vaginalis (IC50 = 60 nM). The potency of compound 1 was 10 times greater than that of metronidazole against both parasites. None of compounds showed in vitro cytotoxicity against VERO cells tested at 100 µM. Molecular dynamics of compounds 1−10, secnidazole, and metronidazole onto the ligand binding site of pyruvate−ferredoxin oxidoreductase of T. vaginalis and the modeled β-tubulin of G. duodenalis revealed putative molecular interactions with key residues in the binding site of both proteins implicated in the mode of action of the parent drugs.